ArticleClinical and translational medicine2026

Endogenous CD155 drives metabolic reprogramming via PI3K/AKT/HIF-1α-glycolysis axis to mediate anti-PD-1 resistance in non-small cell lung cancer.

Wei-Guang Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.